Chiome Bioscience Inc.

Direct answer

Chiome Bioscience Inc. is publicly traded on JPX under the ticker 4583.T.

Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. It operates in two segments, Drug Discovery Business and Drug Discovery Support Business. The company offers ADLib System, a technology for generating monoclonal antibodies which is used to generate antibodies for drug discovery research; and Human ADLib System, which converts chicken antibody genes to...

Can you invest in Chiome Bioscience Inc.?

Yes. Chiome Bioscience Inc. is publicly traded on JPX under the ticker 4583.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Chiome Bioscience Inc.

Detailed equity research is provided by MarketSnap.